Targeting AKT and DNA-PK as a therapeutic strategy in platinum-resistant high-grade serous ovarian cancer

被引：0
|
作者：
Rinne, N. [1 ]
Curry, E. [1 ]
Fotopoulou, C. [1 ]
Gabra, H. [1 ,2 ]
Cunnea, P. [1 ]
机构：
[1] Imperial Coll London, Ovarian Canc Act Res Ctr, Dept Canc & Surg, London, England
[2] AstraZeneca, IMED Biotech Unit, Early Clin Dev, Cambridge, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1985
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [1] TARGETING AKT AND DNA-PK AS A THERAPEUTIC STRATEGY IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
    Rinne, N.
    Fotopoulou, C.
    Cunnea, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A231 - A232
  • [2] TARGETING AKT AND DNA-PK AS A THERAPEUTIC STRATEGY IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
    Rinne, N.
    Curry, E.
    Fotopoulou, C.
    Gabra, H.
    Cunnea, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A512 - A513
  • [3] TARGETING AKT AND DNA-PK AS A THERAPEUTIC STRATEGY IN PLATINUM RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
    Rinne, Natasha
    Yuan, Shengnan
    Fotopoulou, Christina
    Gabra, Hani
    Cunnea, Paula
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A62 - A62
  • [4] Differentially expressed genes in platinum-resistant high-grade serous ovarian cancer
    Corey, Logan
    Alvero, Ayesha
    Tiwari, Nivedita
    You, Yuan
    Rattan, Ramandeep
    Kim, Seongho
    Mor, Gil
    Gogoi, Radhika
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S130 - S131
  • [5] Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
    Ganapathi, Ram N.
    Norris, Eric J.
    Sutker, Ashley P.
    Klotz, Kaitlin E.
    Ganapathi, Mahrukh K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [6] Genetic variation in platinum-sensitive and platinum-resistant high-grade serous epithelial ovarian cancer
    Castellano, Tara
    Clark, Leslie H.
    Rashid, Naim
    Bae-Jump, Victoria
    CANCER RESEARCH, 2017, 77
  • [7] Targeting aurora A kinase (AAK) in platinum-resistant high grade serous ovarian cancer (HGSOC)
    Ganapathi, Ram N.
    Norris, Eric J.
    Sutker, Ashley P.
    Soliman, Hala
    Ganapathi, Mahrukh K.
    CANCER RESEARCH, 2019, 79 (13)
  • [8] A platinum-resistant subtype of high-grade serous ovarian cancer identified by a network of somatic mutations.
    Shen, John P.
    Bojorquez-Gomez, Ana
    Huang, Justin
    Hofree, Matan
    Kurnit, Katie
    Klepper, Kristin
    Beckett, Alex
    Kreisberg, Jason F.
    Saenz, Cheryl C.
    Ideker, Trey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Biomarkers of outcome with weekly paclitaxel in platinum-resistant high-grade serous or endometrioid ovarian carcinoma
    Madariaga, A.
    Garg, S.
    Bruce, J.
    Rath, P.
    Mandilaras, V.
    Thiryayi, S.
    Oza, A. M.
    Dhani, N.
    Lee, Y. C.
    Clarke, B. A.
    Lheureux, S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 149 - 149
  • [10] Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer
    Greenman, Michelle
    Bellone, Stefania
    Demirkiran, Cem
    Hartwich, Tobias Max Philipp
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 54
12345